Ramtech Building Systems Executives to Present at 2026 World of Modular Convention
Ramtech Building Systems’ President Matt Slataper and Vice President of Business Development Kelly Williams will deliver a joint presentation titled “Navigating... Read more.
Iyuno Announces a Revolutionary Innovation in Global Content Localization and Beyond
BURBANK, Calif., March 31, 2026 /PRNewswire/ — Iyuno, a leading provider of media localization services, today announced the development and early introduction... Read more.
Beyond the Build: Five Robotics Practices That Connect Students to Purpose, Partners, and Possibility
BOSTON, March 31, 2026 /PRNewswire/ — Many schools across the U.S. offer robotics through a technical elective or club centered on coding, building, and competition.... Read more.
Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Granted Orphan Drug Designation by EMA for Hepatocellular Carcinoma
SHANGHAI, March 31, 2026 /PRNewswire/ — 31 March 2026, Abbisko Therapeutics Co., Ltd. (“Abbisko Therapeutics” hereafter, HKEX code: 02256) announced... Read more.
transcosmos announces its Purpose, Vision, and Values for the next phase of growth
Upholding its Purpose—Make It Real Together. By transcending limits and connecting people through technology, we open a universe of possibilities for growth and... Read more.
The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step
Issued on behalf of Avaí Bio, Inc. USANewsGroup.com VANCOUVER, BC, March 31, 2026 /PRNewswire/ — The FDA has approved more than 40 cell and gene therapy products.... Read more.
Hanon Systems Supplies Highly Integrated Cooling Entity for Electric Vehicles
SEOUL, South Korea, March 31, 2026 /PRNewswire/ — Hanon Systems (KS:018880), a leading global automotive thermal management supplier and subsidiary of Hankook... Read more.
Direct Digital Holdings Reports Fourth Quarter and Full Year 2025 Financial Results
Fourth Quarter 2025 Buy-side Revenue Increased 28% Fourth Quarter 2025 Consolidated Revenue Decreased 7% Reduced Operating Expenses by 12% in Q4 2025 Compared to... Read more.
NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development
PRINCETON, N.J. and TOKYO, March 31, 2026 /PRNewswire/ — NJ Bio, Inc. (“NJ Bio”), a leading provider of integrated drug discovery and development... Read more.
Palico Cuts Secondaries Fees to 5bps Above $50M
NEW YORK, March 31, 2026 /PRNewswire/ — Palico is taking a major step forward in the evolution of the secondary market. With pricing set at just 5 basis points... Read more.